These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21283614)

  • 1. The case for reactive mass oral cholera vaccinations.
    Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
    Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
    Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
    PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.
    Azman AS; Luquero FJ; Ciglenecki I; Grais RF; Sack DA; Lessler J
    PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
    Schaetti C; Hutubessy R; Ali SM; Pach A; Weiss MG; Chaignat CL; Khatib AM
    BMC Public Health; 2009 Apr; 9():99. PubMed ID: 19351401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
    Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
    Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stemming cholera tides in Zimbabwe through mass vaccination.
    Mukandavire Z; Manangazira P; Nyabadza F; Cuadros DF; Musuka G; Morris JG
    Int J Infect Dis; 2020 Jul; 96():222-227. PubMed ID: 32371191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.
    Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Ciglenecki I; Luquero FJ; Azman AS; Cabrol JC
    Lancet Infect Dis; 2017 Apr; 17(4):e123-e127. PubMed ID: 28109819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
    Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
    [No Abstract]   [Full Text] [Related]  

  • 11. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.
    Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Muller V; Llosa AE; Uzzeni F; Luquero FJ; Ciglenecki I; Azman AS
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005652. PubMed ID: 28594891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.
    Sauvageot D; Saussier C; Gobeze A; Chipeta S; Mhango I; Kawalazira G; Mengel MA; Legros D; Cavailler P; M'bang'ombe M
    Vaccine; 2017 Sep; 35(38):5194-5200. PubMed ID: 28803712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of reactive vaccination in controlling cholera outbreaks: an exploratory analysis using a Zimbabwean experience.
    Kim SY; Choi Y; Mason PR; Rusakaniko S; Goldie SJ
    S Afr Med J; 2011 Sep; 101(9):659-64. PubMed ID: 21920160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of and challenges for cholera vaccines in Africa.
    von Seidlein L; Jiddawi M; Grais RF; Luquero F; Lucas M; Deen J
    J Infect Dis; 2013 Nov; 208 Suppl 1():S8-14. PubMed ID: 24101650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
    Schwerdtle P; Onekon CK; Recoche K
    Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.
    Anh DD; Lopez AL; Thiem VD; Grahek SL; Duong TN; Park JK; Kwon HJ; Favorov M; Hien NT; Clemens JD
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e1006. PubMed ID: 21283616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling endemic cholera with oral vaccines.
    Longini IM; Nizam A; Ali M; Yunus M; Shenvi N; Clemens JD
    PLoS Med; 2007 Nov; 4(11):e336. PubMed ID: 18044983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.